Back to Search Start Over

Financial costs of assisted reproductive technology for patients in low- and middle-income countries: a systematic review

Authors :
Njagi, Purity
Groot, Wim
Arsenijevic, Jelena
Dyer, Silke
Mburu, Gitau
Kiarie, James
Njagi, Purity
Groot, Wim
Arsenijevic, Jelena
Dyer, Silke
Mburu, Gitau
Kiarie, James
Source :
Human Reproduction Open vol.2023 (2023) nr.2 p.1-17 [ISSN 2399-3529]
Publication Year :
2023

Abstract

STUDY QUESTION: What are the direct costs of assisted reproductive technology (ART), and how affordable is it for patients in low- and middle-income countries (LMICS)?SUMMARY ANSWER: Direct medical costs paid by patients for infertility treatment are significantly higher than annual average income and GDP per capita, pointing to unaffordability and the risk of catastrophic expenditure for those in need.WHAT IS KNOWN ALREADY: Infertility treatment is largely inaccessible to many people in LMICs. Our analysis shows that no study in LMICs has previously compared ART medical costs across countries in international dollar terms (US$PPP) or correlated the medical costs with economic indicators, financing mechanisms, and policy regulations. Previous systematic reviews on costs have been limited to high-income countries while those in LMICs have only focussed on descriptive analyses of these costs.STUDY DESIGN SIZE DURATION: Guided by the preferred reporting items for systematic reviews and meta-analyses (PRISMA), we searched PubMed, Web of Science, Cumulative Index of Nursing and Allied Health Literature, EconLit, PsycINFO, Latin American & Caribbean Health Sciences Literature, and grey literature for studies published in all languages from LMICs between 2001 and 2020.PARTICIPANTS/MATERIALS SETTING METHODS: The primary outcome of interest was direct medical costs paid by patients for one ART cycle. To gauge ART affordability, direct medical costs were correlated with the GDP per capita or average income of respective countries. ART regulations and public financing mechanisms were analyzed to provide information on the healthcare contexts in the countries. The quality of included studies was assessed using the Integrated Quality Criteria for Review of Multiple Study designs.MAIN RESULTS AND THE ROLE OF CHANCE: Of the 4062 studies identified, 26 studies from 17 countries met the inclusion criteria. There were wide disparities across

Details

Database :
OAIster
Journal :
Human Reproduction Open vol.2023 (2023) nr.2 p.1-17 [ISSN 2399-3529]
Notes :
DOI: 10.1093/hropen/hoad007, English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1445831597
Document Type :
Electronic Resource